Your browser is no longer supported. Please, upgrade your browser.
Settings
MYOK MyoKardia, Inc. daily Stock Chart
MYOK [NASD]
MyoKardia, Inc.
Index- P/E- EPS (ttm)-0.74 Insider Own2.30% Shs Outstand35.49M Perf Week8.77%
Market Cap1.91B Forward P/E- EPS next Y-1.89 Insider Trans-79.17% Shs Float31.12M Perf Month41.79%
Income-24.30M PEG- EPS next Q-0.41 Inst Own90.20% Short Float4.62% Perf Quarter47.40%
Sales45.40M P/S42.17 EPS this Y54.10% Inst Trans-0.04% Short Ratio3.57 Perf Half Y288.13%
Book/sh7.36 P/B7.33 EPS next Y-16.00% ROA-11.50% Target Price56.17 Perf Year349.58%
Cash/sh6.97 P/C7.75 EPS next 5Y- ROE-14.90% 52W Range10.55 - 54.00 Perf YTD28.15%
Dividend- P/FCF208.12 EPS past 5Y- ROI-9.20% 52W High-0.09% Beta-
Dividend %- Quick Ratio7.10 Sales past 5Y- Gross Margin- 52W Low411.37% ATR2.38
Employees98 Current Ratio7.10 Sales Q/Q55.60% Oper. Margin-55.90% RSI (14)77.94 Volatility5.07% 5.11%
OptionableYes Debt/Eq0.00 EPS Q/Q-21.20% Profit Margin-53.50% Rel Volume1.59 Prev Close52.90
ShortableYes LT Debt/Eq0.00 EarningsFeb 01 AMC Payout- Avg Volume402.81K Price53.95
Recom1.70 SMA2019.84% SMA5033.56% SMA20085.35% Volume640,192 Change1.98%
Jan-18-18Resumed Credit Suisse Outperform $60
Dec-12-17Initiated JP Morgan Overweight $54
Sep-19-17Reiterated Credit Suisse Outperform $45 → $55
Dec-04-15Initiated Wells Fargo Outperform
Nov-23-15Initiated Wedbush Outperform $22
Nov-23-15Initiated Credit Suisse Outperform $18
Jan-19-18 08:30AM  MyoKardia Announces Appointment of Cynthia Ladd as General Counsel GlobeNewswire
Jan-16-18 03:50PM  Edited Transcript of MYOK earnings conference call or presentation 2-Nov-17 8:30pm GMT Thomson Reuters StreetEvents
Jan-10-18 12:08PM  4 Biotechs with Near Term Catalysts: G1 Therapeutics, Inc. (GTHX), Sierra Oncology Inc (SRRA), Myokardia Inc (MYOK), Jounce Therapeutics (JNCE) SmarterAnalyst
Jan-03-18 04:30PM  MyoKardia to Present at 36th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Dec-26-17 11:51AM  ETFs with exposure to MyoKardia, Inc. : December 26, 2017 Capital Cube
Dec-25-17 09:21AM  MyoKardia, Inc. :MYOK-US: Earnings Analysis: Q3, 2017 By the Numbers : December 25, 2017 Capital Cube
Dec-11-17 07:25AM  MyoKardia, Inc. breached its 50 day moving average in a Bullish Manner : MYOK-US : December 11, 2017 Capital Cube
Nov-15-17 08:00AM  Preclinical Studies with MyoKardias Mavacamten Demonstrate Evidence of Reduced Contractility and Improved Left Ventricular Compliance GlobeNewswire
Nov-13-17 07:15PM  MyoKardia Presents Data from Study of Machine Learning Algorithm Intended to Identify Obstructive Hypertrophic Cardiomyopathy Using a Wearable Biosensor GlobeNewswire
Nov-08-17 09:44AM  MyoKardia, Inc. Value Analysis (NASDAQ:MYOK) : November 8, 2017 Capital Cube
Nov-07-17 12:48PM  Myokardia Inc (MYOK) Q3:17 Update At First Glance SmarterAnalyst
Nov-06-17 07:17AM  MyoKardia, Inc. breached its 50 day moving average in a Bullish Manner : MYOK-US : November 6, 2017 Capital Cube
Nov-02-17 05:54PM  MyoKardia reports 3Q loss Associated Press
04:02PM  MyoKardia Reports Third Quarter 2017 Financial Results and Operational Progress GlobeNewswire
Nov-01-17 08:00AM  MyoKardia Announces Presentations at 2017 American Heart Association Scientific Sessions GlobeNewswire
Oct-31-17 08:00AM  MyoKardia to Present at Two Upcoming Investor Conferences in November GlobeNewswire
Oct-26-17 08:00AM  MyoKardia to Announce Third Quarter 2017 Financial Results on Thursday, November 2, 2017 GlobeNewswire
Oct-12-17 08:24AM  MyoKardia, Inc. breached its 50 day moving average in a Bearish Manner : MYOK-US : October 12, 2017 Capital Cube
Oct-10-17 11:39AM  ETFs with exposure to MyoKardia, Inc. : October 10, 2017 Capital Cube
Oct-09-17 09:51AM  MyoKardia, Inc. :MYOK-US: Earnings Analysis: Q2, 2017 By the Numbers : October 9, 2017 Capital Cube
Oct-02-17 10:50AM  Best Sector ETF of Q3 and its Top-Performing Stocks Zacks
Sep-27-17 07:30AM  MyoKardia Provides Update on MYK-491 Clinical Progress GlobeNewswire
Sep-25-17 07:01PM  Cramer's lightning round: Why I can't go down the path of... CNBC Videos -5.20%
06:48PM  Cramer's lightning round: Why I can't go down the path of US Steel CNBC
Sep-18-17 04:45PM  MyoKardia Unveils More Phase 2 Data on Heart Disease Treatment TheStreet.com
12:45PM  MyoKardia Presents Additional Positive Data from Phase 2 PIONEER-HCM Study of Mavacamten (Formerly MYK-461) at the Heart Failure Society of Americas 21st Annual Scientific Meeting GlobeNewswire
Aug-30-17 08:00AM  MyoKardia to Present at Two Upcoming Investor Conferences in September GlobeNewswire
Aug-16-17 08:58AM  MyoKardia (MYOK) Looks Good: Stock Adds 6.32% in Session Zacks +5.69%
Aug-14-17 11:14AM  MyoKardia Announces Closing of Public Offering of Common Stock Including Full Exercise of Option to Purchase Additional Shares GlobeNewswire
Aug-10-17 08:00AM  MyoKardia to Present at 2017 Wedbush PacGrow Healthcare Conference GlobeNewswire
Aug-09-17 07:30AM  [$$] Zinsli's Take: Biotech's Saviors Keep Up VCs' Hopes The Wall Street Journal
Aug-08-17 08:16PM  MyoKardia Announces Pricing of Public Offering of Common Stock GlobeNewswire +15.10%
04:21PM  Edited Transcript of MYOK earnings conference call or presentation 7-Aug-17 12:30pm GMT Thomson Reuters StreetEvents
04:12PM  MyoKardia Inc. Is on the Rise Again Today -- Here's Why Motley Fool
Aug-07-17 11:59PM  MyoKardia reports 2Q loss Associated Press +83.38%
04:20PM  Why NxStage Medical, MyoKardia, and Rockwell Collins Jumped Today Motley Fool
04:01PM  MyoKardia Announces Proposed Public Offering of Common Stock GlobeNewswire
03:14PM  MyoKardia Shares Almost Double on Latest Clinical Data for Heart Disease Treatment TheStreet.com
12:25PM  Here's Why Myokardia Inc. Stock Shot Up Today Motley Fool
07:34AM  MyoKardia shares surge 32% on positive mid-stage trial results for heart muscle disease MarketWatch
07:19AM  MyoKardia Reports Second Quarter 2017 Financial Results and Operational Progress GlobeNewswire
07:00AM  MyoKardia Reports Positive Topline Results in Phase 2 PIONEER-HCM Study of Mavacamten (Formerly MYK-461) in Symptomatic, Obstructive Hypertrophic Cardiomyopathy GlobeNewswire
Jul-31-17 08:01AM  MyoKardia to Announce Second Quarter 2017 Financial Results and Host Conference Call on Monday, August 7, 2017 GlobeNewswire
Jul-24-17 05:30PM  ETFs with exposure to MyoKardia, Inc. : July 24, 2017 Capital Cube
Jul-21-17 08:37AM  MyoKardia, Inc. breached its 50 day moving average in a Bullish Manner : MYOK-US : July 21, 2017 Capital Cube
Jul-14-17 03:47PM  ETFs with exposure to MyoKardia, Inc. : July 14, 2017 Capital Cube
Jul-12-17 03:31PM  MyoKardia, Inc. Value Analysis (NASDAQ:MYOK) : July 12, 2017 Capital Cube
Jul-11-17 08:23AM  MyoKardia, Inc. breached its 50 day moving average in a Bullish Manner : MYOK-US : July 11, 2017 Capital Cube
Jun-28-17 09:01AM  MyoKardia, Inc. breached its 50 day moving average in a Bearish Manner : MYOK-US : June 28, 2017 Capital Cube
Jun-15-17 02:42PM  ETFs with exposure to MyoKardia, Inc. : June 15, 2017 Capital Cube
Jun-09-17 09:21AM  MyoKardia, Inc. :MYOK-US: Earnings Analysis: Q1, 2017 By the Numbers : June 9, 2017 Capital Cube
Jun-02-17 08:39AM  MyoKardia, Inc. breached its 50 day moving average in a Bullish Manner : MYOK-US : June 2, 2017 Capital Cube
May-09-17 06:44PM  MyoKardia reports 1Q loss Associated Press
04:02PM  MyoKardia Reports First Quarter 2017 Financial Results and Operational Progress GlobeNewswire
02:15PM  Investor Network: MyoKardia, Inc. to Host Earnings Call Accesswire
May-02-17 08:30AM  MyoKardia to Announce First Quarter 2017 Financial Results and Host Conference Call on Tuesday, May 9, 2017 GlobeNewswire
Apr-26-17 04:21PM  MyoKardia, Inc. Value Analysis (NASDAQ:MYOK) : April 26, 2017 Capital Cube
Apr-25-17 08:58AM  MyoKardia, Inc. breached its 50 day moving average in a Bullish Manner : MYOK-US : April 25, 2017 Capital Cube
Apr-18-17 08:30AM  MyoKardia Appoints David Meeker, M.D., to Board of Directors GlobeNewswire
Apr-13-17 12:36PM  ETFs with exposure to MyoKardia, Inc. : April 13, 2017 Capital Cube
Apr-06-17 08:27AM  MyoKardia, Inc. breached its 50 day moving average in a Bearish Manner : MYOK-US : April 6, 2017 Capital Cube
Mar-23-17 12:13PM  MyoKardia, Inc. :MYOK-US: Earnings Analysis: Q4, 2016 By the Numbers : March 23, 2017 Capital Cube
10:11AM  MyoKardia, Inc. :MYOK-US: Earnings Analysis: 2016 By the Numbers : March 23, 2017
Mar-17-17 01:04PM  MYOKARDIA INC Financials
08:30AM  MyoKardia Appoints Kim Popovits and Wendy Yarno to Board of Directors GlobeNewswire
Mar-13-17 09:11AM  MYOKARDIA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
08:40AM  MyoKardia reports 4Q loss Associated Press
08:30AM  MyoKardia Reports Fourth Quarter and Full Year 2016 Financial Results and Operational Progress GlobeNewswire
Mar-10-17 07:50AM  MyoKardia, Inc. breached its 50 day moving average in a Bullish Manner : MYOK-US : March 10, 2017 Capital Cube
Mar-06-17 07:17AM  MYOKARDIA INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Mar-02-17 07:00AM  7 Stocks Trending With Monster Volume TheStreet.com
Feb-28-17 08:30AM  MyoKardia to Present at Cowen and Company 37th Annual Health Care Conference GlobeNewswire
Feb-17-17 07:50AM  MyoKardia, Inc. breached its 50 day moving average in a Bullish Manner : MYOK-US : February 17, 2017 Capital Cube
Feb-02-17 08:30AM  First Subjects Dosed in Phase 1 Study of Dilated Cardiomyopathy Candidate MYK-491 GlobeNewswire
Feb-01-17 05:19PM  MYOKARDIA INC Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Stat +6.70%
08:30AM  MyoKardia Announces Appointment of June Lee, M.D., as Chief Operating Officer and Radhika Tripuraneni, M.D., as Vice President, Medical Affairs GlobeNewswire
Jan-03-17 08:41AM  MYOKARDIA INC Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
08:30AM  MyoKardia Announces Advancement to Next Phase of Global Collaboration with Sanofi GlobeNewswire
Dec-12-16 02:42PM  ETFs with exposure to MyoKardia, Inc. : December 12, 2016
Dec-09-16 03:21AM  Is Myokardia Inc (MYOK) A Good Stock To Buy? at Insider Monkey
Dec-08-16 08:00AM  MyoKardia to Present at 2016 BMO Capital Markets Healthcare Conference GlobeNewswire -5.23%
Dec-05-16 08:15AM  Blog Coverage MyoKardia Announced Receipt of Payment from Sanofi Accesswire
Dec-02-16 08:00AM  MyoKardia Announces Receipt of Milestone Payment from Sanofi for DCM Candidate MYK-491 GlobeNewswire
Dec-01-16 11:42AM  ETFs with exposure to MyoKardia, Inc. : December 1, 2016
08:00AM  MyoKardia Announces Appointment of Marc Semigran, M.D., as Chief Medical Officer GlobeNewswire
07:33AM  MyoKardia, Inc. breached its 50 day moving average in a Bearish Manner : MYOK-US : December 1, 2016
Nov-21-16 11:11AM  MyoKardia, Inc. :MYOK-US: Earnings Analysis: Q3, 2016 By the Numbers : November 21, 2016
Nov-15-16 02:01PM  ETFs with exposure to MyoKardia, Inc. : November 15, 2016
Nov-14-16 07:57AM  MyoKardia, Inc. breached its 50 day moving average in a Bullish Manner : MYOK-US : November 14, 2016
Nov-11-16 08:00AM  MyoKardia Announces Exploratory Digital Health Substudy as Part of PIONEER-HCM Trial of MYK-461 in Symptomatic, Obstructive Hypertrophic Cardiomyopathy Patients GlobeNewswire +7.45%
Nov-07-16 09:01AM  MYOKARDIA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
08:25AM  MyoKardia reports 3Q loss
08:00AM  MyoKardia Reports Progress on Clinical Programs and Third Quarter 2016 Financial Results GlobeNewswire
Nov-04-16 08:00AM  MyoKardia Announces Presentations at American Heart Association Scientific Sessions 2016 GlobeNewswire +10.34%
Nov-02-16 08:00AM  MyoKardia Announces Dosing of First Patient in Phase 2 PIONEER-HCM Study of MYK-461 in Symptomatic, Obstructive Hypertrophic Cardiomyopathy GlobeNewswire
Oct-31-16 08:00AM  MyoKardia to Present at Two Upcoming Investor Conferences in November GlobeNewswire
Oct-03-16 04:30PM  MyoKardia Announces Closing of Public Offering of Common Stock Including Full Exercise of Option to Purchase Additional Shares GlobeNewswire
Sep-28-16 03:14PM  Heres Why These Five Stocks Are Trading Higher Today at Insider Monkey +5.95%
Sep-27-16 06:48PM  MyoKardia Announces Pricing of Proposed Public Offering of Common Stock GlobeNewswire
Sep-26-16 04:48PM  MyoKardia Announces Proposed Public Offering of Common Stock GlobeNewswire -6.15%
Clinical-stage biotech developing therapies for heritable cardiomyopathies.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GIANAKAKOS ANASTASIOSPresident and CEOJan 12Option Exercise1.515,0007,534514,117Jan 16 06:47 PM
Lambing JosephSee RemarksJan 12Sale50.005,000250,00095,846Jan 16 06:46 PM
GIANAKAKOS ANASTASIOSPresident and CEOJan 12Sale50.005,000250,000509,117Jan 16 06:47 PM
Bauer JakeSee RemarksJan 09Sale45.005,000225,00056,777Jan 10 04:45 PM
GIANAKAKOS ANASTASIOSPresident and CEOJan 04Option Exercise1.513,0004,520512,117Jan 05 05:27 PM
GIANAKAKOS ANASTASIOSPresident and CEOJan 04Sale41.703,000125,103509,117Jan 05 05:27 PM
STARR KEVIN PDirectorJan 03Sale42.00816,32634,285,774680,272Jan 05 04:30 PM
Third Rock Ventures III, L.P.10% OwnerJan 03Sale42.00816,32634,285,774680,272Jan 05 04:30 PM
Bauer JakeSee RemarksJan 02Sale42.895,000214,46661,777Jan 03 08:06 PM
GIANAKAKOS ANASTASIOSPresident and CEODec 21Option Exercise1.513,0004,520512,117Dec 26 04:46 PM
GIANAKAKOS ANASTASIOSPresident and CEODec 21Sale41.093,000123,268509,117Dec 26 04:46 PM
GIANAKAKOS ANASTASIOSPresident and CEONov 06Option Exercise1.514,3006,479513,417Nov 08 06:04 PM
GIANAKAKOS ANASTASIOSPresident and CEONov 06Sale40.234,300172,990509,117Nov 08 06:04 PM
GIANAKAKOS ANASTASIOSPresident and CEOOct 04Option Exercise1.514,3006,479512,463Oct 06 06:49 PM
GIANAKAKOS ANASTASIOSPresident and CEOOct 04Sale40.864,300175,699508,163Oct 06 06:49 PM
STARR KEVIN PDirectorOct 03Sale40.2875,3133,033,57870,763Oct 04 04:00 PM
STARR KEVIN PDirectorSep 26Sale43.00400,00017,200,0006,885,104Sep 27 04:00 PM
Third Rock Ventures II, L.P.10% OwnerSep 26Sale43.00400,00017,200,0006,885,104Sep 27 04:01 PM
Third Rock Ventures II, L.P.10% OwnerSep 25Sale43.00201,4008,660,2007,285,104Sep 27 04:01 PM
STARR KEVIN PDirectorSep 25Sale43.00201,4008,660,2007,285,104Sep 27 04:00 PM
Third Rock Ventures II, L.P.10% OwnerSep 11Sale44.2520,000885,08057,651Sep 12 04:05 PM
STARR KEVIN PDirectorSep 08Sale41.01201,2508,252,4997,486,504Sep 12 04:05 PM
Third Rock Ventures II, L.P.10% OwnerSep 08Sale41.01201,2508,252,4997,486,504Sep 12 04:05 PM
GIANAKAKOS ANASTASIOSPresident and CEOSep 05Option Exercise1.514,3006,479512,463Sep 07 04:06 PM
GIANAKAKOS ANASTASIOSPresident and CEOSep 05Sale43.024,300185,004508,163Sep 07 04:06 PM
Lambing JosephSee RemarksAug 22Sale45.005,000225,00099,718Aug 24 04:05 PM
Lambing JosephSee RemarksAug 15Sale40.005,000200,000104,718Aug 16 04:32 PM
Sanofi10% OwnerAug 14Buy35.50350,00012,425,0004,018,899Aug 16 07:31 AM
YARNO WENDY LDirectorAug 14Buy35.501,40849,9841,408Aug 16 04:33 PM
Lambing JosephSee RemarksAug 08Sale35.005,000175,000109,718Aug 09 05:16 PM
Lambing JosephSee RemarksAug 07Sale27.5010,000275,000114,718Aug 09 05:16 PM
Bauer JakeSee RemarksAug 07Sale28.3315,000425,00065,545Aug 09 05:15 PM
GIANAKAKOS ANASTASIOSPresident and CEOAug 04Option Exercise1.514,3006,479512,463Aug 04 09:31 PM
GIANAKAKOS ANASTASIOSPresident and CEOAug 04Sale16.624,30071,465508,163Aug 04 09:31 PM
GIANAKAKOS ANASTASIOSPresident and CEOJul 25Option Exercise1.5131,85048,094541,151Jul 27 05:11 PM
GIANAKAKOS ANASTASIOSPresident and CEOJul 25Sale15.0032,988494,902508,163Jul 27 05:11 PM
Bauer JakeSee RemarksJul 25Sale15.024,33365,06080,545Jul 27 05:11 PM
GIANAKAKOS ANASTASIOSPresident and CEOMar 20Option Exercise1.511,2001,812509,454Mar 22 08:39 PM
GIANAKAKOS ANASTASIOSPresident and CEOMar 20Sale15.001,41221,180508,042Mar 22 08:39 PM
Bauer JakeSee RemarksMar 20Sale15.0066710,00583,900Mar 22 08:37 PM